0001801198-24-000043 | 6-K | XBRL Viewer

OTHER PAYABLES AND ACCRUALS (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Disclosure Of Other Payables And Accruals [Abstract]
Accrued payroll	$ 39,417	$ 30,974
Accrued expense	99,841	71,462
Payable for collaboration assets	8,563	16,338
Other tax payables	1,963	2,084
Total	$ 164,864	$ 132,802

LEASES - Additional Information (Details) $ in Millions	9 Months Ended
Sep. 30, 2024 USD ($)
Leases [Line Items]
Lessee, lease terms	50 years
Ongoing lease payments	$ 0.0

PREPAYMENTS, OTHER RECEIVABLES AND OTHER ASSETS (Details) - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Disclosure Of Prepayments Other Receivables And Other Assets [Line Items]
Other collaboration receivables	$ 96,819	$ 54,078
Total	$ 112,801	$ 69,251

COVER	9 Months Ended
Sep. 30, 2024
Cover [Abstract]
Document Type	6-K
Entity Registrant Name	Legend Biotech Corporation
Entity Central Index Key	0001801198
Document Period End Date	Sep. 30, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--12-31
Amendment Flag	false

Label

Element

Value

Share Capital And Share Premium Number Of Shares In Issue

legn_ShareCapitalAndSharePremiumNumberOfSharesInIssue

363,822,069

Share Capital And Share Premium Number Of Shares In Issue

legn_ShareCapitalAndSharePremiumNumberOfSharesInIssue

366,901,007

Share Capital And Share Premium

legn_ShareCapitalAndSharePremium

$ 36,000

Share Capital And Share Premium

legn_ShareCapitalAndSharePremium

2,637,120,000

Share Capital And Share Premium

legn_ShareCapitalAndSharePremium

2,637,156,000

Share Capital And Share Premium

legn_ShareCapitalAndSharePremium

37,000

Share Capital And Share Premium

legn_ShareCapitalAndSharePremium

2,685,727,000

Share Capital And Share Premium

legn_ShareCapitalAndSharePremium

2,685,764,000

License Revenue

legn_LicenseRevenue

120,123,000

License Revenue

legn_LicenseRevenue

35,172,000

License Revenue

legn_LicenseRevenue

75,100,000

License Revenue

legn_LicenseRevenue

45,000,000

Decrease (increase) in pledged short-term deposits

legn_DecreaseIncreaseInPledgedShortTermDeposits

Decrease (increase) in pledged short-term deposits

legn_DecreaseIncreaseInPledgedShortTermDeposits

922,000

Collaboration Revenue

legn_CollaborationRevenue

314,563,000

Collaboration Revenue

legn_CollaborationRevenue

$ 170,369,000

Disclosure Of Movements In Company Share Capital And Share Premium Explanatory [Table Text Block]

legn_DisclosureOfMovementsInCompanyShareCapitalAndSharePremiumExplanatoryTableTextBlock

A summary of movements in the Company’s share capital and share premium is as follows:


	Number of shares in issue	Share capital	Share premium	Total
		US$’000	US$’000	US$’000
At December 31, 2023 and January 1, 2024	363,822,069	36	2,637,120	2,637,156
Exercise of share options	1,517,492	—	14,011	14,011
Reclassification of vesting of restricted share units	1,561,446	1	34,596	34,597
At September 30, 2024 (Unaudited)	366,901,007	37	2,685,727	2,685,764

Adjustments For Depreciation Of Right Of Use Assets

legn_AdjustmentsForDepreciationOfRightOfUseAssets

$ 7,041,000

Adjustments For Depreciation Of Right Of Use Assets

legn_AdjustmentsForDepreciationOfRightOfUseAssets

5,680,000

Cash Receipts Of Investment Income Classified As Investing Activities

legn_CashReceiptsOfInvestmentIncomeClassifiedAsInvestingActivities

2,467,000

Cash Receipts Of Investment Income Classified As Investing Activities

legn_CashReceiptsOfInvestmentIncomeClassifiedAsInvestingActivities

6,402,000

Collaboration Prepaid Leases

legn_CollaborationPrepaidLeases

172,981,000

Collaboration Prepaid Leases

legn_CollaborationPrepaidLeases

151,216,000

Adjustment For Fair Value Gain (Loss) Of Warrant Liability

legn_AdjustmentForFairValueGainLossOfWarrantLiability

Adjustment For Fair Value Gain (Loss) Of Warrant Liability

legn_AdjustmentForFairValueGainLossOfWarrantLiability

85,750,000

Other Finance Gains

legn_OtherFinanceGains

21,000

Other Finance Gains

legn_OtherFinanceGains

166,000

Times Deposits Non Current

legn_TimesDepositsNonCurrent

4,509,000

Times Deposits Non Current

legn_TimesDepositsNonCurrent

4,362,000

Reclassification Of Vested Restricted Stock Units Share Capital And Share Premium

legn_ReclassificationOfVestedRestrictedStockUnitsShareCapitalAndSharePremium

1,000

Reclassification Of Vested Restricted Stock Units Share Capital And Share Premium

legn_ReclassificationOfVestedRestrictedStockUnitsShareCapitalAndSharePremium

34,596,000

Reclassification Of Vested Restricted Stock Units Share Capital And Share Premium

legn_ReclassificationOfVestedRestrictedStockUnitsShareCapitalAndSharePremium

$ 34,597,000

Disclosure Of Deferred Revenue From Customer Contract Liabilities [Text Block]

legn_DisclosureOfDeferredRevenueFromCustomerContractLiabilitiesTextBlock

The following table shows the deferred revenue which is included in contract liabilities for the periods presented:


	September 30,	December 31
	2024	2023
	US$’000 (Unaudited)	US$’000
Contract liabilities (Current)	63,161	53,010
Contract liabilities (Non-Current)	—	47,962
Total	63,161	100,972

Future Estimated Milestone Payments

legn_FutureEstimatedMilestonePayments

$ 1,010,000,000.00

Prepayment To Collaborator For Collaboration Right Of Use Assets

legn_PrepaymentToCollaboratorForCollaborationRightOfUseAssets

49,110,000

Prepayment To Collaborator For Collaboration Right Of Use Assets

legn_PrepaymentToCollaboratorForCollaborationRightOfUseAssets

80,218,000

Deferred Government Grant

legn_DeferredGovernmentGrant

(430,000)

Deferred Government Grant

legn_DeferredGovernmentGrant

(484,000)

Proceeds From Issuance Of Ordinary Shares For Institutional Investors, Net Of Issuance Costs

legn_ProceedsFromIssuanceOfOrdinarySharesForInstitutionalInvestorsNetOfIssuanceCosts

Proceeds From Issuance Of Ordinary Shares For Institutional Investors, Net Of Issuance Costs

legn_ProceedsFromIssuanceOfOrdinarySharesForInstitutionalInvestorsNetOfIssuanceCosts

234,410,000

Cost Of License And Other Revenue

legn_CostOfLicenseAndOtherRevenue

13,693,000

Cost Of License And Other Revenue

legn_CostOfLicenseAndOtherRevenue

Interest Bearing Borrowings Funded Interests Accrued

legn_InterestBearingBorrowingsFundedInterestsAccrued

46,600,000

Proceeds From (Purchase Of) Intangible Assets, Classified As Investing Activities

legn_ProceedsFromPurchaseOfIntangibleAssetsClassifiedAsInvestingActivities

Proceeds From (Purchase Of) Intangible Assets, Classified As Investing Activities

legn_ProceedsFromPurchaseOfIntangibleAssetsClassifiedAsInvestingActivities

(134,000)

Proceeds From Issuance Of Ordinary Shares For Follow On Public Offering Net Of Issuance Costs

legn_ProceedsFromIssuanceOfOrdinarySharesForFollowOnPublicOfferingNetOfIssuanceCosts

Proceeds From Issuance Of Ordinary Shares For Follow On Public Offering Net Of Issuance Costs

legn_ProceedsFromIssuanceOfOrdinarySharesForFollowOnPublicOfferingNetOfIssuanceCosts

349,278,000

Other Income And Gains

legn_OtherIncomeAndGains

49,148,000

Other Income And Gains

legn_OtherIncomeAndGains

49,812,000

Proceeds From Exercise Of Warrant By Warrant Holder, Net Of Issuance Cost

legn_ProceedsFromExerciseOfWarrantByWarrantHolderNetOfIssuanceCost

Proceeds From Exercise Of Warrant By Warrant Holder, Net Of Issuance Cost

legn_ProceedsFromExerciseOfWarrantByWarrantHolderNetOfIssuanceCost

199,741,000

Adjustments For Decrease Increase In Prepayments Other Receivable Other Assets

legn_AdjustmentsForDecreaseIncreaseInPrepaymentsOtherReceivableOtherAssets

(43,929,000)

Adjustments For Decrease Increase In Prepayments Other Receivable Other Assets

legn_AdjustmentsForDecreaseIncreaseInPrepaymentsOtherReceivableOtherAssets

(6,413,000)

Increase (Decrease) Through Reclassification Of Vested Restricted Stock Equity